Deerfield Special Situations Fund, L.P.

CIK 1354395 · last filed 2019-10-30

Deerfield Special Situations Fund, L.P. is a corporate insider who has filed 37 SEC Form 4 insider transactions across 20 companies since 2007. The most recent filing, for CABA, was dated Oct 30, 2019. Across all open-market trades the lifetime net is +$754.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $286.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$286.25M

Companies

20

Total Filings

37

Lifetime Open-Market Net

$754.43M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CABA 10%+ Owner 700,000 $3.01 $2.11M $53.90M 1 2019-10-30
Korro Bio, Inc. (FREQ) Delisted 10%+ Owner 472,860 $14.98 $7.08M $28.00M 1 2019-10-07
ACRS 3,159,165 $4.32 $13.65M -$19.84M 3 2019-07-01
XERS 10%+ Owner 873,520 $6.79 $5.93M -$11.93M 2 2019-02-07
CBIO 10%+ Owner 1,113,222 $17.92 $19.95M -$8.76M 1 2018-03-08
RYTM 10%+ Owner 468,505 $88.38 $41.41M $36.21M 1 2017-10-10
AXGN 10%+ Owner 3,000,000 $43.00 $129.00M -$2.74M 1 2016-07-21
EHTH 10%+ Owner 1,062,874 $1.81 $1.92M -$17.47M 1 2016-06-22
STREAMLINE HEALTH SOLUTIONS INC. (STRM) Delisted 10%+ Owner 1,875,500 $5.33 $10.00M -$1.95M 1 2015-12-17
CTMX 10%+ Owner 160,512 $3.01 $483.1K $45.00M 1 2015-10-14
ANTARES PHARMA, INC. (ATRS) Delisted 10%+ Owner 7,037,014 $5.59 $39.34M -$10.29M 1 2015-06-26
Auspex Pharmaceuticals, Inc. (ASPX) Delisted 10%+ Owner 953,286 $736.80M 2 2015-01-28
Dicerna Pharmaceuticals Inc (DRNA) Delisted 10%+ Owner 293,949 $38.22 $11.23M -$21.95M 1 2014-11-25
DUSA 10%+ Owner 1,278,032 $56.18 $71.80M -$4.36M 2 2011-03-22
NeuroMetrix, Inc. (NURO) Delisted 10%+ Owner 1,190,280 $4.58 $5.45M -$2.24M 1 2010-09-17
NxStage Medical, Inc. (NXTM) Delisted 10%+ Owner 1,231,478 -$9.89M 3 2009-12-15
NITROMED INC (NTMD) Delisted 10%+ Owner 3,580,090 $449.5K 4 2008-08-06
DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted 10%+ Owner $15.50 $0 2 2008-06-30
INSPIRE PHARMACEUTICALS INC (ISPH) Delisted 10%+ Owner 413,293 -$21.83M 1 2007-05-02
THIRD WAVE TECHNOLOGIES INC /WI (TWTI) Delisted 10%+ Owner 1,763,136 -$12.68M 3 2007-04-27

Recent Filings

37 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-10-30 CABA Mixed +11,399,542 $53.90M EDGAR
2019-10-07 Korro Bio, Inc. (FREQ) Delisted Mixed +8,620,038 $28.00M EDGAR
2019-07-01 ACRS Sell (S) −3,497,375 -$9.41M EDGAR
2019-06-25 ACRS Sell (S) −2,271,305 -$10.43M EDGAR
2019-02-07 XERS Sell (S) −88,842 -$1.33M EDGAR
2019-01-25 XERS Sell (S) −686,664 -$10.60M EDGAR
2019-01-18 ACRS Other (J) $0 EDGAR
2018-03-08 CBIO Sell (S) −287,112 -$8.76M EDGAR
2017-10-10 RYTM Mixed +5,622,060 $36.21M EDGAR
2016-07-21 AXGN Sell (S) −408,544 -$2.74M EDGAR
Showing 110 of 37
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.